VERU INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERU INC. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $79.48K, a 68.75% increase year-over-year.
- VERU INC. stock issued during period, value, stock options exercised for the quarter ending 2022-12-31 was $257.13K, a 22.52% increase year-over-year.
- VERU INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $153.95K, a 41.92% decline year-over-year.
- VERU INC. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $47.10K, a 92.75% decline year-over-year.
- VERU INC. stock issued during period, value, stock options exercised for fiscal 2023 was $389.06K, a 63.92% decline from fiscal 2022.
- VERU INC. stock issued during period, value, stock options exercised for fiscal 2022 was $1.08M, a 39.27% decline from fiscal 2021.
- VERU INC. stock issued during period, value, stock options exercised for fiscal 2021 was $1.78M, a 327.37% increase from fiscal 2020.
- VERU INC. stock issued during period, value, stock options exercised for fiscal 2020 was $415.46K, a 24.76% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-09-30 | $389.06K 10-K/A · filed 2024-04-01 | |
| 2023-03-31 | $79.48K 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $257.13K 10-Q · filed 2024-05-08 | |
| 2022-09-30 | $1.08M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $153.95K 10-Q/A · filed 2023-11-15 | |
| 2022-03-31 | $47.10K 10-Q/A · filed 2023-11-15 | |
| 2021-12-31 | $209.87K 10-Q/A · filed 2023-11-15 | |
| 2021-09-30 | $1.78M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $265.05K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $649.27K 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $623.82K 10-Q · filed 2022-08-11 | |
| 2020-09-30 | $415.46K 10-K · filed 2021-12-02 | |
| 2020-06-30 | $6.83K 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $408.63K 10-Q · filed 2021-08-12 | |
| 2019-09-30 | $333.00K 10-K · filed 2020-12-10 | |
| 2019-03-31 | $200.00K 10-Q · filed 2020-08-13 | |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $66.00K 10-K · filed 2019-12-12 |
| 2018-06-30 | $66.00K 10-Q · filed 2019-08-08 | |
| 2010-09-30 | $157.90K 10-K · filed 2012-12-04 | |
| 2009-09-30 | $449.37K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |